| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CL | Common Stock | Options Exercise | $387K | +5.39K | +22.78% | $71.76 | 29.1K | Feb 3, 2022 | Direct | F1 |
| transaction | CL | Common Stock | Sale | -$448K | -5.39K | -18.55% | $83.16 | 23.7K | Feb 3, 2022 | Direct | F2, F3 |
| holding | CL | Common Stock | 27.9K | Feb 3, 2022 | By Trust | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CL | Stock Option (Right to Buy) | Options Exercise | $0 | -5.39K | -100% | $0.00* | 0 | Feb 3, 2022 | Common Stock | 5.39K | $71.76 | Direct | F1, F5 |
| Id | Content |
|---|---|
| F1 | Exercise of stock options awarded under the issuer's incentive compensation plan. |
| F2 | Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. |
| F3 | Weighted average price, as these shares were sold in multiple transactions at prices ranging from $83.1501 to $83.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | This amount includes 2,159 shares that were previously reported as directly beneficially owned. |
| F5 | Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date. |